WHO ICTRP trial
A study to evaluate clear skin effect in patients with plaque psoriasis.
EUCTR2015-003701-42-ES · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2015-003701-42-ES |
|---|---|
| Public title | A study to evaluate clear skin effect in patients with plaque psoriasis. |
| Scientific title | An open-label, prospective, non-randomized, multicenter study to evaluate clear skin effect on health related quality of life outcomes at 16 and 52 weeks in patients with moderate to severe plaque psoriasis treated with secukinumab 300 mg s.c. with or without previous exposure to systemic therapy. |
| Primary sponsor | Novartis Farmacéutica, S.A. |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): yes |
| Countries | Portugal;Slovakia;Greece;Spain;Lithuania;Israel;Russian Federation;United Kingdom;European Union;Belgium;Poland;Germany;Latvia |
| Conditions | Plaque psoriasis MedDRA version: 18.1 Level: LLT Classification code 10050576 Term: Psoriasis vulgaris System Organ Class: 100000004858 ;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17] |
| Interventions | Trade Name: Cosentyx Product Name: Cosentyx (secukinumab) Product Code: AIN457 Pharmaceutical Form: Solution for injection in pre-filled syringe INN or Proposed INN: Secukinumab CAS Number: 1229022-83-6 Current Sponsor code: AIN457 Other… |
| Registration date | Dec 28, 2015 |
| Target size | 1615 |
| Secondary IDs | CAIN457A3401 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: